Drug HCPCS codes no longer requiring a paper invoice (JN)
To reduce provider burden, certain contractor priced HCPCS codes no longer require a paper invoice.
When the invoice information is entered in the narrative field on a claim for any of the HCPCS codes listed below, it is not necessary to provide the actual paper invoice for these services. For details, view our article on the process for supplying invoice amount on certain HCPCS codes to avoid rejected claims.
| Code | Description | Effective "from" date of service |
Effective "through" date of service |
|---|---|---|---|
| J0120 | Injection, tetracycline, up to 250 mg | 1/1/2025 | Present |
| J0209 | Injection, sodium thiosulfate (hope), 100 mg | 4/1/2024 | Present |
| J0211 | Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote) | 7/1/2024 | Present |
| J0220 | Injection, alglucosidase alfa, 10 mg, not otherwise specified | 1/1/2024 | Present |
| J0300 | Injection, amobarbital, up to 125 mg | 1/1/2025 | Present |
| J0350 | Injection, anistreplase, per 30 units | 1/1/2025 | Present |
| J0364 | Injection, apomorphine hydrochloride, 1 mg | 1/1/2025 | Present |
| J0380 | Injection, metaraminol bitartrate, per 10 mg | 1/1/2024 | Present |
| J0390 | Injection, chloroquine HCL, up to 250 mg | 1/1/2024 | Present |
| J0400 | Injection, aripiprazole, intramuscular, 0.25 mg | 1/1/2024 | Present |
| J0470 | Injection, dimercaprol, per 100 mg | 1/1/2025 | Present |
| J0520 | Injection, bethanechol chloride, myotonachol or Urecholine, up to 5 mg | 1/1/2025 | Present |
| J0571 | Buprenorphine, oral, 1 mg | 1/1/2024 | Present |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 1/1/2024 | Present |
| J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | 1/1/2024 | Present |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 1/1/2024 | Present |
| J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine | 1/1/2024 | Present |
| J0576 | Injection, buprenorphine extended release (Brixadi), 1 mg | 1/1/2025 | Present |
| J0591 | Injection, deoxycholic acid, 1 mg | 1/1/2025 | Present |
| J0600 | Edetate calcium disodium, up to 1000 mg | 1/1/2024 | 12/31/2024 |
| J0620 | Injection, calcium glycerophosphate and calcium lactate, per 10 ml | 1/1/2024 | Present |
| J0650 | Injection, levothyroxine sodium, not otherwise specified, 10 mcg | 4/1/2024 | 12/31/2024 |
| J0715 | Injection, ceftizoxime sodium, per 500 mg | 1/1/2025 | Present |
| J0716 | Injection, Centruroides immune f(ab)2, up to 120 mg | 1/1/2024 | Present |
| J0745 | Injection, codeine phosphate, per 30 mg | 1/1/2025 | Present |
| J0799 | Injection, Lenacpavir when used for HIV PrEP | 6/18/25 | 9/30/25 |
| J0945 | Injection, brompheniramine maleate, per 10 mg | 1/1/2025 | Present |
| J1094 | Injection, dexamethasone acetate, 1 mg | 1/1/2025 | Present |
| J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram | 1/1/2025 | Present |
| J1130 | Injection, diclofenac sodium, 0.5 mg | 1/1/2025 | Present |
| J1180 | Injection, dyphylline, up to 500 mg | 1/1/2024 | Present |
| J1260 | Injection, dolasetron mesylate, 10 mg | 1/1/2025 | Present |
| J1320 | Injection, amitriptyline HCL, up to 20 mg | 1/1/2025 | Present |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | 4/1/2024 | 12/31/2024 |
| J1435 | Injection, estrone, per 1 mg | 1/1/2025 | Present |
| J1436 | Injection, etidronate disodium, per 300 mg | 1/1/2024 | Present |
| J1444 | Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron | 1/1/2025 | Present |
| J1562 | Injection, immune globulin (Vivaglobin), 100 mg | 1/1/2024 | Present |
| J1598 | Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to J1596, 0.1 mg | 7/1/2024 | 9/30/2024 |
| J1599 | Injection, immune globulin, intravenous, nonlyophilized (e.g., liquid), not otherwise specified, 500 mg | 1/1/2024 | Present |
| J1600 | Injection, gold sodium thiomalate, up to 50 mg | 1/1/2024 | Present |
| J1620 | Injection, gonadorelin hydrochloride, per 100 mcg | 1/1/2025 | Present |
| J1655 | Injection, tinzaparin sodium, 1000 iu | 1/1/2025 | Present |
| J1675 | Injection, histrelin acetate, 10 mcg | 1/1/2024 | Present |
| J1700 | Injection, hydrocortisone acetate, up to 25 mg | 1/1/2025 | Present |
| J1710 | Injection, hydrocortisone sodium phosphate, up to 50 mg | 1/1/2024 | Present |
| J1726 | Injection, hydroxyprogesterone caproate, (Makena), 10 mg | 1/1/2025 | Present |
| J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg | 1/1/2024 | Present |
| J1730 | Injection, diazoxide, up to 300 mg | 1/1/2025 | Present |
| J1749 | Injection, iloprost, 0.1 mcg | 10/1/2024 | 6/30/2025 |
| J1810 | Injection, droperidol and fentanyl citrate, up to 2 ml ampule | 1/1/2024 | Present |
| J1815 | Injection, insulin, per 5 units | 1/1/2025 | Present |
| J1830 | Injection, interferon beta-1b, 0.25 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) | 1/1/2025 | Present |
| J1835 | Injection, itraconazole, 50 mg | 1/1/2025 | Present |
| J1840 | Injection, kanamycin sulfate, up to 500 mg | 1/1/2024 | Present |
| J1850 | Injection, kanamycin sulfate, up to 75 mg | 1/1/2024 | Present |
| J1890 | Injection, cephalothin sodium, up to 1 g | 1/1/2024 | Present |
| J1960 | Injection, levorphanol tartrate, up to 2 mg | 1/1/2025 | Present |
| J1980 | Injection, hyoscyamine sulfate, up to 0.25 mg | 1/1/2025 | Present |
| J1990 | Injection, chlordiazepoxide HCL, up to 100 mg | 1/1/2024 | Present |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 10/1/2024 | Present |
| J2004 | Injection, lidocaine HCL with epinephrine, 1 mg | 10/1/2024 | Present |
| J2180 | Injection, meperidine and promethazine HCL, up to 50 mg | 1/1/2024 | Present |
| J2246 | Injection, micafungin in sodium (Baxter), not therapeutically equivalent to J2248, 1 mg | 1/1/2025 | Present |
| J2252 | Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | 10/1/2024 | 12/31/2024 |
| J2253 | Injection, midazolam (seizalam), 1 mg | 10/1/2024 | Present |
| J2290 | Injection, nafcillin sodium, 20 mg | 1/1/2025 | 6/30/2025 |
| J2320 | Injection, nandrolone decanoate, up to 50 mg | 1/1/2025 | Present |
| J2326 | Injection, nusinersen, 0.1 mg | 1/1/2025 | Present |
| J2355 | Injection, oprelvekin, 5 mg | 1/1/2024 | Present |
| J2371 | Injection, nusinersen, 0.1 mg | 1/1/2025 | 3/31/2025 |
| J2400 | Injection, chloroprocaine HCL, per 30 ml | 1/1/2024 | Present |
| J2410 | Injection, oxymorphone HCL, up to 1 mg | 1/1/2024 | Present |
| J2460 | Injection, oxytetracycline HCL, up to 50 mg | 1/1/2025 | Present |
| J2468 | Injection, palonosetron hydrochloride (avyxa), not therapeutically equivalent to J2469, 25 micrograms | 7/1/2024 | 12/31/2024 |
| J2503 | Injection, pegaptanib sodium, 0.3 mg | 1/1/2025 | Present |
| J2504 | Injection, pegademase bovine, 25 IU | 1/1/2024 | Present |
| J2510 | Injection, penicillin g procaine, aqueous, up to 600,000 units | 1/1/2025 | Present |
| J2513 | Injection, pentastarch, 10% solution, 100 ml | 1/1/2024 | Present |
| J2650 | Injection, prednisolone acetate, up to 1 ml | 1/1/2024 | Present |
| J2670 | Injection, tolazoline HCL, up to 25 mg | 1/1/2024 | Present |
| J2725 | Injection, protirelin, per 250 mcg | 1/1/2024 | Present |
| J2730 | Injection, pralidoxime chloride, up to 1 g | 1/1/2024 | 12/31/2024 |
| J2770 | Injection quinupristin/dalfopristin 500mg/ (150/3520) | 1/1/2024 | Present |
| J2780 | Injection, ranitidine HCL, 25 mg | 1/1/2024 | Present |
| J2797 | Injection, rolapitant, 0.5 mg | 1/1/2024 | Present |
| J2810 | Injection, theophylline, per 40 mg | 1/1/2024 | Present |
| J2941 | Injection, somatropin, 1 mg | 1/1/2025 | Present |
| J2950 | Injection, promazine HCL, up to 25 mg | 1/1/2025 | Present |
| J2993 | Injection, reteplase, 18.1 mg | 1/1/2024 | Present |
| J3070 | Injection, pentazocine, 30 mg | 1/1/2025 | Present |
| J3265 | Injection, torsemide, 10 mg/ml | 1/1/2024 | Present |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 1/1/2025 | 3/31/2025 |
| J3302 | Injection, triamcinolone diacetate, per 5 mg | 1/1/2024 | Present |
| J3303 | Injection, triamcinolone hexacetonide, per 5 mg | 1/1/2024 | 12/31/2024 |
| J3310 | Injection, perphenazine, up to 5 mg | 1/1/2024 | Present |
| J3316 | Injection, triptorelin, extended release, 3.75 mg | 1/1/2024 | 12/31/2024 |
| J3350 | injection, urea, up to 40 g | 1/1/2024 | Present |
| J3355 | Injection, urofollitropin, 75 IU | 1/1/2024 | Present |
| J3364 | Injection, urokinase, 5000 iu vial | 1/1/2025 | Present |
| J3365 | Injection, iv, urokinase, 250,000 iu. vial | 1/1/2025 | Present |
| J3391 | Injection, atidarsagene autotemcel, per | 7/1/2025 | Present |
| J3392 | Injection, exagamglogene autotemcel, per treatment | 1/1/2025 | Present |
| J3400 | Injection, triflupromazine HCL, up to 20 mg | 1/1/2024 | Present |
| J3471 | Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) | 1/1/2025 | Present |
| J3472 | Injection, hyaluronidase, ovine, preservative free, per 1,000 USP units | 1/1/2024 | Present |
| J3520 | Edetate disodium, per 150 mg | 1/1/2025 | Present |
| J7100 | Infusion, dextran 40, 500 ml | 1/1/2025 | Present |
| J7110 | Infusion, dextran 75, 500 ml | 1/1/2024 | Present |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 1/1/2025 | Present |
| J7131 | Hypertonic saline solution, 1 ml | 1/1/2024 | Present |
| J7191 | Factor VIII (antihemophilic factor (porcine)), per IU | 1/1/2024 | Present |
| J7196 | Injection, antithrombin recombinant, 50 IU | 1/1/2024 | Present |
| J7199 | Hemophilia clotting factor, not otherwise classified | 1/1/2025 | Present |
| J7310 | Ganciclovir, 4.5 mg, long-acting implant | 1/1/2024 | Present |
| J7315 | Mitomycin, ophthalmic, 0.2 mg | 1/1/2024 | Present |
| J7330 | Autologous cultured chondrocytes, implant | 1/1/2024 | Present |
| J7352 | Afamelanotide implant, 1 mg | 1/1/2024 | Present |
| J8999 | Prescription drug, oral, chemotherapeutic, NOS | 1/1/2025 | Present |
| J9020 | Injection, asparaginase, not otherwise specified, 10,000 units | 1/1/2024 | Present |
| J9051 | Injection, bortezomib (Maia), not therapeutically equivalent to j9041, 0.1 mg | 1/1/2024 | Present |
| J9064 | Injection, cabazitaxel (Sandoz), not therapeutically equivalent to j9043, 1 mg | 1/1/2025 | Present |
| J9072 | Injection, cyclophosphamide, (Dr. Reddy's), 5 mg | 1/1/2024 | 6/30/2024 |
| J9074 | Injection, cyclophosphamide (Sandoz), 5 mg | 4/1/2024 | 6/30/2024 |
| J9098 | Injection, cytarabine liposome, 10 mg | 1/1/2024 | Present |
| J9151 | Injection, daunorubicin citrate, liposomal formulation, 10 mg | 1/1/2024 | Present |
| J9161 | Injection, denileukin diftitox-cxdl, 1 mcg | 4/1/2025 | Present |
| J9175 | Injection, Elliott’s' b solution, 1 ml | 1/1/2025 | Present |
| J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg | 4/1/2024 | Present |
| J9213 | Injection, interferon, alfa-2a, recombinant, 3 million units | 1/1/2024 | Present |
| J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units | 10/1/2023 | Present |
| J9219 | Leuprolide acetate implant, 65 mg | 1/1/2024 | Present |
| J9220 | Injection, indigotindisulfonate sodium, 1 mg | 7/1/2025 | Present |
| J9225 | Histrelin implant (Vantas), 50 mg | 1/1/2024 | Present |
| J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg | 1/1/2025 | Present |
| J9247 | Injection, melphalan flufenamide, 1 mg | 1/1/2024 | Present |
| J9249 | Injection, melphalan (apotex), 1 mg | 4/1/2024 | Present |
| J9255 | Injection, methotrexate (accord) not therapeutically equivalent to j9250 and j9260, 50 mg | 1/1/2024 | 12/31/2024 |
| J9258 | Injection, paclitaxel protein-bound particles (Teva) not therapeutically equivalent to j9264, 1 mg | 1/1/2024 | 7/1/2024 |
| J9275 | Injection, cosibelimab-ipdl, 2 mg | 7/1/2025 | Present |
| J9296 | Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg | 1/1/2025 | Present |
| J9302 | Injection, ofatumumab, 10 mg | 1/1/2025 | Present |
| J9320 | Injection, streptozocin, 1 gram | 3/17/2025 | Present |
| J9322 | Injection, pemetrexed (Bluepoint) not therapeutically equivalent to J9305, 10 mg | 1/1/2024 | Present |
| J9324 | Injection, pemetrexed (pemrydi rtu), 10 mg | 1/1/2024 | 2/29/2024 |
| J9361 | Injection, efbemalenograstim alfa-vuxw, 0.5 mg | 7/1/2024 | Present |
| J9371 | Injection, vincristine sulfate liposome, 1 mg | 1/1/2025 | Present |
| J9393 | Injection, fulvestrant (Teva) not therapeutically equivalent to j9395, 25 mg | 1/1/2024 | Present |
| Q5098 | Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg | 7/1/2025 | Present |
| Q5133 | Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg | 4/1/2024 | 4/30/2024 |
| Q5134 | Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg | 4/1/2024 | Present |
| Q5136 | Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg | 10/1/2023 | Present |
| Q5137 | Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg | 7/1/2024 | 12/31/2024 |
| Q5138 | Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg | 7/1/2024 | 12/31/2024 |
| Q5139 | Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg | 1/1/2025 | Present |
| Q5149 | Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg | 4/1/2025 | Present |
| Q5150 | Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg | 4/1/2025 | Present |
| Q5153 | Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg | 7/1/2025 | Present |
| Q9996 | Injection, ustekinumab-ttwe (Pyzchiva), subcutaneous, 1 mg | 1/1/2025 | Present |
| Q9997 | Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg | 1/1/2025 | Present |
| Q9998 | Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg | 1/1/2025 | 6/30/2025 |